Pfizer Applies for US FDA Approval for Omicron-Adapted Vaccine Booster in Under 5 Kids
Pfizer and BioNTech has submitted an application to the US Food and Drug Administration (FDA) for emergency use authorization of the Omicron-adapted COVID-19 vaccine booster for children under 5 years. If the vaccine is authorized, the children would receive the primary series of the vaccine consisting of two doses of the original COVID-19 vaccine developed […]
Continue Reading